Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling

Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

(2021) Antonio Lopez-Beltran et al.   Cancers

Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome

(2021) YiHeng Du et al.   Frontiers in Oncology

Deciphering the temporal heterogeneity of cancer-associated fibroblast subpopulations in breast cancer

(2021) Freja Albjerg Venning et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types

(2021) Bingrui Li et al.   ONCOGENE

Evolution of fibroblasts in the lung metastatic microenvironment is driven by stage-specific transcriptional plasticity

(2021) Ophir Shani et al.   eLife

m6A-Related lncRNA to Develop Prognostic Signature and Predict the Immune Landscape in Bladder Cancer

(2021) Zuwei Li et al.   Journal of Oncology

A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

(2020) Vinata B. Lokeshwar et al.   CLINICAL CANCER RESEARCH

CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer

(2020) Haiyang Zhang et al.   Molecular Cancer

CD73 on cancer-associated fibroblasts enhanced by the A2B-mediated feedforward circuit enforces an immune checkpoint

(2020) Miao Yu et al.   Nature Communications

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

(2020) Lynette M. Sholl et al.   Journal of Thoracic Oncology

Senescence and the SASP: many therapeutic avenues

(2020) Jodie Birch et al.   GENES & DEVELOPMENT

Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology

(2019) Gregor Sturm et al.   BIOINFORMATICS

KRAS activation in gastric adenocarcinoma stimulates epithelial-to-mesenchymal transition to cancer stem-like cells and promotes metastasis

(2019) Changhwan Yoon et al.   MOLECULAR CANCER RESEARCH

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

(2019) Ela Elyada et al.   Cancer Discovery

Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome

(2019) Xiaofan Lu et al.   NEOPLASIA

A Consensus Molecular Classification of Muscle-invasive Bladder Cancer

(2019) Aurélie Kamoun et al.   EUROPEAN UROLOGY

Prognostic power of a lipid metabolism gene panel for diffuse gliomas

(2019) Fan Wu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Development and External Validation of a Novel 12-Gene Signature for Prediction of Overall Survival in Muscle-Invasive Bladder Cancer

(2019) MierXiati Abudurexiti et al.   Frontiers in Oncology

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

(2018) Tathiane M. Malta et al.   CELL

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance

(2018) Tianyi Wang et al.   Cell Metabolism

X chromosome protects against bladder cancer in females via aKDM6A-dependent epigenetic mechanism

(2018) Satoshi Kaneko et al.   Science Advances

Surface-Enhanced Raman Scattering Nanoparticles for Multiplexed Imaging of Bladder Cancer Tissue Permeability and Molecular Phenotype

(2018) Ryan M. Davis et al.   ACS Nano

Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases

(2018) Ana Luisa Cardoso et al.   AGEING RESEARCH REVIEWS

The effects of cancer-associated fibroblasts obtained from atypical ductal hyperplasia on anti-tumor immune responses

(2018) Betul Gok Yavuz et al.   Breast Journal

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

(2018) Sanjeev Mariathasan et al.   NATURE

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

(2018) Peng Jiang et al.   NATURE MEDICINE

Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma

(2018) Zhengui Zhou et al.   Aging-US

Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy

(2017) Georgios Gakis et al.   EUROPEAN UROLOGY

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity

(2017) Akash Patnaik et al.   Cancer Discovery

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

(2016) Samuel A. Funt et al.   Nature Reviews Clinical Oncology

Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published Studies

(2016) Liu Liu et al.   PLoS One

Robust enumeration of cell subsets from tissue expression profiles

(2015) Aaron M Newman et al.   NATURE METHODS

Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer

(2015) Isaiah G. Schauer et al.   NEOPLASIA

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

(2014) Berna C. Özdemir et al.   CANCER CELL

Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines

(2014) Paul Geeleher et al.   GENOME BIOLOGY

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

The role of the myofibroblast in tumor stroma remodeling

(2012) Marcela Otranto et al.   Cell Adhesion & Migration